PUBLISHER: The Insight Partners | PRODUCT CODE: 1871467
PUBLISHER: The Insight Partners | PRODUCT CODE: 1871467
The Middle East and Africa (MEA) positive airway pressure (PAP) devices market is projected to grow from US$ 251.81 million in 2023 to US$ 292.08 million by 2031, reflecting a compound annual growth rate (CAGR) of 1.9% during this period.
Executive Summary and Market Analysis
The MEA PAP devices market is categorized into key regions including Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The anticipated growth in this market is driven by several factors: increased investments in healthcare development, rising healthcare expenditures, government initiatives, collaborations among market players, and a growing prevalence of sleep apnea. Additionally, various associations and institutes are actively supporting the advancement of the sleep apnea treatment sector.
Market Segmentation Analysis
The MEA PAP devices market can be segmented based on product type, application, and end user:
Market Outlook
PAP devices are essential for maintaining open airways during sleep, significantly enhancing cognitive function and sleep quality for individuals suffering from sleep apnea and other respiratory disorders. The introduction of innovative PAP devices, such as CPAP and BiPAP, addresses the increasing demand for effective treatment of respiratory diseases. The rising awareness and diagnosis of sleep apnea, particularly obstructive sleep apnea (OSA), are key drivers of demand. Furthermore, the growing incidence of respiratory diseases, including COPD, is contributing to market growth. According to the World Health Organization (WHO), COPD was responsible for 3.5 million deaths globally in 2021, making it the fourth leading cause of death worldwide. The majority of COPD-related deaths occur in low- and middle-income countries (LMIC), highlighting the urgent need for effective treatment options like PAP devices.
Country Insights
The MEA PAP devices market is further analyzed by country, with Saudi Arabia holding the largest market share in 2023. The increasing prevalence of sleep apnea in Saudi Arabia is a significant factor driving market growth. Reports indicate that the elderly population in Saudi Arabia is expected to increase dramatically, with the number of individuals aged 60 and above projected to rise from 2 million in 2020 to 10.5 million by 2050. As sleep apnea is more common among older adults, this demographic shift is likely to boost the demand for PAP devices in the coming years.
Moreover, market players are pursuing both organic and inorganic growth strategies to enhance their market presence. For example, in March 2022, Avon Protection showcased its respiratory protection products, including the MP-PAPR and FM50 respirator, at the inaugural World Defense Show in Riyadh, Saudi Arabia.
Company Profiles
Key players in the PAP devices market include ICU Medical Inc., React Health (formerly 3B Medical, Inc.), Fisher & Paykel Healthcare Corp Ltd, BPL Medical Technologies Pvt Ltd, Koninklijke Philips NV, Dragerwerk AG & Co KGaA, ResMed Inc., Vyaire Medical Inc., Wellell Inc., Armstrong Medical Ltd, Lowenstein Medical UK Ltd., BMC Medical Co Ltd, and Narang Medical Limited, among others. These companies are focusing on strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.